Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation

CompletedOBSERVATIONAL
Enrollment

1,300

Participants

Timeline

Start Date

January 1, 2004

Primary Completion Date

May 31, 2020

Study Completion Date

June 30, 2020

Conditions
Heart TransplantationAllograft Arteriopathy
Interventions
OTHER

Latent class mixed modeling

To identify CAV trajectories after heart transplantation using a contemporary unsupervised trajectory-based approach known as latent class mixed modeling

Trial Locations (3)

75015

Paris Transplant Group, Paris

90211

Jon Kobashigawa, Los Angeles

Unknown

Maarten Naesens, Leuven

All Listed Sponsors
collaborator

Groupe Hospitalier Pitie-Salpetriere

OTHER

collaborator

European Georges Pompidou Hospital

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

lead

Paris Translational Research Center for Organ Transplantation

OTHER

NCT04117152 - Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation | Biotech Hunter | Biotech Hunter